# Jame Abraham

Source: https://onco.cc/people/jame-abraham/  
OnCo record `jame-abraham` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Jame Abraham leads medical oncology at Cleveland Clinic and its breast cancer trial programme.

## Summary

Jame Abraham is Chair of the Department of Hematology and Medical Oncology at Cleveland Clinic Taussig Cancer Institute. He is a breast medical oncologist known for leading Cleveland Clinic's breast cancer trial programme and for his role on the NCCN breast cancer guideline panel. His selected paper reports the ATEMPT trial of adjuvant trastuzumab emtansine versus paclitaxel with trastuzumab for stage I HER2-positive breast cancer. He leads medical oncology at Cleveland Clinic and remains an investigator in adjuvant and metastatic breast cancer trials, with an interest in cancer care delivery.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Chair, Department of Hematology and Medical Oncology
- Specialisms: Breast cancer; Clinical trials; Cancer care delivery

## Sources

- Cleveland Clinic profile: https://my.clevelandclinic.org/staff/17181-jame-abraham
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Abraham%20J%5BAuthor%5D

## Connected records

- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- institutions: [Cleveland Clinic Taussig Cancer Institute](https://onco.cc/institutions/cleveland-clinic/)

---
JSON: https://onco.cc/api/v1/entities/jame-abraham.json